Ruo-Yu Ma
Overview
Explore the profile of Ruo-Yu Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
350
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang S, Lai Y, Liao H, Chang C, Ma R, Chen Y, et al.
Elife
. 2025 Jan;
13.
PMID: 39835538
Natural killer (NK) cells can control metastasis through cytotoxicity and IFN-γ production independently of T cells in experimental metastasis mouse models. The inverse correlation between NK activity and metastasis incidence...
2.
Qian B, Ma R
Adv Exp Med Biol
. 2025 Jan;
1464():413-432.
PMID: 39821036
Metastatic disease is the final stage of breast cancer that accounts for vast majority of patient death. Mounting data over recent years strongly support the critical roles of the immune...
3.
Guo J, Ma R, Qian B
J Bone Oncol
. 2024 Apr;
45:100598.
PMID: 38585688
Previous studies illustrated that macrophage, a type of innate immune cell, plays critical roles in tumour progression and metastasis. Bone is the most frequent site of metastasis for several cancer...
4.
Li X, Selli C, Zhou H, Cao J, Wu S, Ma R, et al.
J Exp Med
. 2023 Feb;
220(4).
PMID: 36749798
Metastatic castration-resistant prostate cancer (PC) is the final stage of PC that acquires resistance to androgen deprivation therapies (ADT). Despite progresses in understanding of disease mechanisms, the specific contribution of...
5.
Yuan T, Chen Y, Liu D, Ma R, Zhang X, Du T, et al.
Neural Regen Res
. 2022 Oct;
18(4):901-907.
PMID: 36204861
There are many documented sex differences in the clinical course, symptom expression profile, and treatment response of Parkinson's disease, creating additional challenges for patient management. Although subthalamic nucleus deep brain...
6.
Ma R, Black A, Qian B
Trends Immunol
. 2022 Jun;
43(7):546-563.
PMID: 35690521
Tumor-associated macrophages (TAMs) have multiple potent functions in cancer and, thus, represent important therapeutic targets. These diverse functions highlight the heterogenous nature of TAMs. Recent single cell omics technologies have...
7.
Ma R, Zhang H, Li X, Zhang C, Selli C, Tagliavini G, et al.
J Exp Med
. 2020 Aug;
217(11).
PMID: 32780802
Bone metastasis is the major cause of death in breast cancer. The lack of effective treatment suggests that disease mechanisms are still largely unknown. As a key component of the...
8.
Lee G, Chang C, Wu Y, Ma R, Chen C, Hsue Y, et al.
J Formos Med Assoc
. 2020 Aug;
120(1 Pt 3):651-659.
PMID: 32741737
Background/purpose: Sjögren's syndrome (SS) is an autoimmune disease and its conventional treatment has exhibited limited therapeutic efficacy. Traditional Chinese medicine has been demonstrated to ameliorate the sicca symptoms of SS...
9.
Ma R
World J Hepatol
. 2020 Jan;
12(1):1-5.
PMID: 31984115
The first editorial board meeting of the () was held on November 8, 2019 at the Side Bar Grille, Sheraton Boston Hotel, Boston, MA, United States. Ruo-Yu Ma, Director of...
10.
Lee G, Lin T, Chen C, Mau S, Huang W, Kao Y, et al.
Brain Behav Immun
. 2018 Jul;
73:562-570.
PMID: 29959050
Acute ischemic stroke is followed by a complex interplay between the brain and the immune system in which ischemia-reperfusion leads to a detrimental inflammatory response that causes brain injury. In...